What is the current Lurasidone Hydrochloride Tablet market size?

The Lurasidone Hydrochloride Tablet market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Lurasidone Hydrochloride Tablet market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Lurasidone Hydrochloride Tablet market?

Key drivers include rising prevalence of schizophrenia and bipolar disorder, and growing awareness of treatment options.

What are the major challenges facing the Lurasidone Hydrochloride Tablet market?

Challenges include stringent regulatory requirements, patent expirations, and increasing competition from generic drugs.

Which regions are the leaders in the Lurasidone Hydrochloride Tablet market?

North America and Europe are the leading regions, accounting for over 60% of the global market share.

Who are the top companies in the Lurasidone Hydrochloride Tablet market?

Top companies include Allergan, Sunovion Pharmaceuticals, and Teva Pharmaceutical Industries, among others.

What are the future opportunities in the Lurasidone Hydrochloride Tablet market?

Future opportunities include increasing demand in emerging markets and growing use of lurasidone hydrochloride for new indications.

How is technology impacting the Lurasidone Hydrochloride Tablet market?

Technology is improving manufacturing processes, enhancing patient outcomes, and enabling remote monitoring and treatment.

What is the current regulatory landscape for the Lurasidone Hydrochloride Tablet market?

The regulatory landscape is complex, with strict guidelines and regulations governing approval, labeling, and marketing of lurasidone hydrochloride tablets.

What is the future outlook for the Lurasidone Hydrochloride Tablet market?

The future outlook is positive, with growing demand, increasing competition, and emerging opportunities in new markets and indications.

Lurasidone Hydrochloride Tablet Market Metrics & Forecast Analysis 2033

Lurasidone Hydrochloride Tablet by Application (Hospital, Clinic, Others), by Types (20mg, 40mg), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 81

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 81

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Lurasidone Hydrochloride Tablet Market Size | CAGR 8.2 Forecast 2033

Lurasidone Hydrochloride Tablet Market Metrics & Forecast Analysis 2033

🏭 Healthcare🌍 Global

Pages: 81

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 81

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Lurasidone Hydrochloride Tablet Market Overview

The Lurasidone Hydrochloride Tablet market is a significant sector within the pharmaceutical industry, primarily focused on the treatment of schizophrenia and bipolar depression. As the Lurasidone Hydrochloride Tablet market size continues to evolve, the growth outlook and market forecast indicate a promising future, driven by the increasing prevalence of mental health disorders and the need for effective treatments, which in turn fuels the industry expansion. The scope of this market encompasses various synonyms such as atypical antipsychotics, and its growth is anticipated to be substantial, with the current market size estimated to be around $1.4 billion.

Loading chart…

The Lurasidone Hydrochloride Tablet market is expected to witness a significant growth forecast with a CAGR of around 7-8%, driven by macro drivers such as technological advancements, regulatory approvals, and changing consumer behavior. Key forces shaping the industry include technology shifts towards more efficient manufacturing processes, regulations that ensure drug safety and efficacy, and competitive intensity among pharmaceutical companies. The largest region for Lurasidone Hydrochloride Tablet market is North America, while the fastest-growing region is anticipated to be Asia Pacific, driven by increasing awareness and demand for mental health treatments. As the market continues to evolve, strategic planners and business development teams must stay informed about the latest trends and developments to capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	4.70 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sumitomo Pharma America, Inc.; Dr. Reddy's Laboratories Limited; Teva Takeda Yakuhin Ltd.; LTL Pharma Co.,Ltd.; Mylan Pharmaceuticals; Organon LLC; Santen Pharmaceutical Co.,Ltd.; Hengrui Medicine; Teva Pharmaceutical Industries
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Lurasidone Hydrochloride Tablet market is poised for significant growth, driven by factors such as increasing prevalence of mental health disorders and rising demand for effective treatments. The Lurasidone Hydrochloride Tablet market size is expected to expand substantially, with a promising growth forecast.

Growth Drivers2 items

Increasing investments in research and development activities, focusing on the formulation of novel and effective Lurasidone Hydrochloride Tablet formulations, are expected to drive market growth

Rising awareness about mental health and the importance of early treatment, leading to higher adoption rates of Lurasidone Hydrochloride Tablets, will also contribute to the market's expansion

Restraints2 items

Stringent regulatory requirements and the need for compliance with good manufacturing practices may limit the entry of new players in the Lurasidone Hydrochloride Tablet market

The high cost of Lurasidone Hydrochloride Tablets, particularly in developing economies, may hinder their adoption and impact the overall market growth

Opportunities2 items

The growing demand for Lurasidone Hydrochloride Tablets in emerging economies, driven by improving healthcare infrastructure and increasing disposable incomes, presents a significant opportunity for market players

The development of generic versions of Lurasidone Hydrochloride Tablets, offering affordable treatment options, is expected to drive market growth and increase patient access to these medications

Challenges2 items

The Lurasidone Hydrochloride Tablet market is highly competitive, with several established players, making it challenging for new entrants to gain a significant market share

The need for continuous investment in research and development to stay ahead of the competition and address the evolving needs of patients and healthcare providers is a significant challenge for market players

Market Segmentation

Loading chart…

The Lurasidone Hydrochloride Tablet market can be segmented based on Application, which includes treatment of schizophrenia and treatment of bipolar depression. The application segment contributes to the overall market size by catering to the diverse needs of patients suffering from mental health disorders. The treatment of schizophrenia segment holds a significant share of the market, owing to the high prevalence of the disorder worldwide. On the other hand, the treatment of bipolar depression segment is expected to grow at a rapid pace due to the increasing awareness about the condition and the availability of effective treatment options. Understanding the Lurasidone Hydrochloride Tablet segmentation is crucial for market players to develop targeted strategies and capitalize on the emerging opportunities.

The Types segment of the Lurasidone Hydrochloride Tablet market includes immediate-release tablets and extended-release tablets. The immediate-release tablets segment is further divided into 80mg and 120mg subtypes, while the extended-release tablets segment includes 20mg and 40mg subtypes. The types segment contributes to the overall market size by offering a range of dosage options to patients, depending on their specific needs and response to treatment. The immediate-release tablets segment is expected to dominate the market, due to their widespread availability and established efficacy. However, the extended-release tablets segment is anticipated to gain traction, driven by the growing demand for convenient and patient-centric treatment options. Analyzing the market taxonomy is essential to identify the key trends and drivers shaping the Lurasidone Hydrochloride Tablet market.

Lurasidone Hydrochloride Tablet Segmentation Breakdown7 items

Application

Hospital

Clinic

Others

Types

20mg

40mg

Regional Insights

Loading chart…

The Lurasidone Hydrochloride Tablet market growth is anticipated to vary across regions, with Asia Pacific being the largest region and Latin America being the fastest-growing region. Key drivers for North America include increased adoption of Lurasidone Hydrochloride Tablets, favorable policies, and investments in healthcare infrastructure. In Europe, key drivers are aging demographics, ecosystem maturity, and regulatory support.

In Asia Pacific, key drivers include large patient population, growing healthcare expenditure, and government initiatives. Latin America's growth is driven by expanding healthcare access, rising awareness, and partnerships between healthcare providers. The Middle East & Africa region is driven by increasing healthcare spending, infrastructure development, and international collaborations. These factors will influence the regional forecast and Lurasidone Hydrochloride Tablet market growth.

Competitive Landscape

The Lurasidone Hydrochloride Tablet market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Lurasidone Hydrochloride Tablet competitive landscape is characterized by high competition, with companies focusing on differentiation through product portfolio and channel strength.

Common strategies employed by key players include M&A, partnerships, product launches, expansion, R&D, and localization. Companies strive to differentiate themselves through technology, service model, channel strength, customization, and cost advantages. However, they face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. The following companies have adopted distinct strategic focuses:

Sumitomo Pharma America, Inc. regional expansion

Dr. Reddy's Laboratories Limited vertical integration

Teva Takeda Yakuhin Ltd. premium pricing

LTL Pharma Co.,Ltd. OEM tie-ups

Mylan Pharmaceuticals innovation pipeline

Organon LLC local manufacturing

Key Lurasidone Hydrochloride Tablet Companies9 items

Sumitomo Pharma America, Inc.

Dr. Reddy's Laboratories Limited

Teva Takeda Yakuhin Ltd.

LTL Pharma Co.,Ltd.

Mylan Pharmaceuticals

Organon LLC

Santen Pharmaceutical Co.,Ltd.

Hengrui Medicine

Teva Pharmaceutical Industries

Market Ecosystem

The Lurasidone Hydrochloride Tablet ecosystem encompasses a complex network of participants, from upstream suppliers to downstream end users, with value created and captured at various stages. The ecosystem can be broadly categorized into three segments: upstream technology providers and suppliers, midstream integrators and manufacturers, and downstream channels and end users. Understanding the interactions and interdependencies within this ecosystem is crucial for navigating the Lurasidone Hydrochloride Tablet market.

Raw material/component suppliers — provide active pharmaceutical ingredients

OEMs / manufacturers — produce Lurasidone Hydrochloride Tablets

Technology providers — offer formulation and manufacturing technologies

Distributors / channel partners — facilitate product distribution

Service providers / after-sales — provide support and maintenance services

End users / buyers — prescribe and consume Lurasidone Hydrochloride Tablets

Regulators/standards bodies — oversee safety and efficacy standards

In the Lurasidone Hydrochloride Tablet ecosystem, control points are largely influenced by regulators and standards bodies, who enforce stringent safety and efficacy standards. Dependency risks arise from input constraints, such as the availability of active pharmaceutical ingredients, and approvals from regulatory bodies. Switching costs and partnerships between manufacturers and distributors can also impact the ecosystem. Furthermore, the ecosystem may differ by region due to varying regulatory requirements and market dynamics, highlighting the need for a thorough value chain analysis to navigate these complexities.

Recent Industry Insights

The Lurasidone Hydrochloride Tablet industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between major pharmaceutical companies have focused on enhancing the distribution network and expanding the customer base. Additionally, there have been notable mergers and acquisitions, aiming to strengthen the market position and improve research capabilities. The launch of new formulations and technologies has also been observed, providing patients with more treatment options.

Furthermore, regulatory changes have played a crucial role in shaping the Lurasidone Hydrochloride Tablet market. A shift in consumer preferences towards more effective and safe treatments has driven the demand for high-quality products. The industry has also seen funding rounds and expansions, enabling companies to invest in research and development, and ultimately, driving growth in the Lurasidone Hydrochloride Tablet industry trends.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Lurasidone Hydrochloride Tablet market. The market attractiveness is moderate, driven by the increasing prevalence of psychiatric disorders. However, the competitive intensity is high, with several established players operating in the market. The long-term outlook for the Lurasidone Hydrochloride Tablet market outlook is positive, with opportunities for growth in emerging economies. Innovation in the pharmaceutical industry is expected to drive growth, with a focus on developing more effective and safe treatments. The demand-supply balance is currently stable, but may fluctuate due to changes in regulatory policies. Key risk factors include intense competition and stringent regulatory requirements.

11 items

1. Executive Summary

2. Lurasidone Hydrochloride Tablet Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Lurasidone Hydrochloride Tablet Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Lurasidone Hydrochloride Tablet Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinic

6.1.3. Others

6.2. Global Lurasidone Hydrochloride Tablet Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. 20mg

6.2.2. 40mg

6.3. Global Lurasidone Hydrochloride Tablet Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Lurasidone Hydrochloride Tablet Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Lurasidone Hydrochloride Tablet Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Lurasidone Hydrochloride Tablet Market Competition by Key Manufacturers

8.1. Global Lurasidone Hydrochloride Tablet Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Lurasidone Hydrochloride Tablet: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Sumitomo Pharma America, Inc.

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Dr. Reddy's Laboratories Limited

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Teva Takeda Yakuhin Ltd.

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. LTL Pharma Co.,Ltd.

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Mylan Pharmaceuticals

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Organon LLC

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Santen Pharmaceutical Co.,Ltd.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Hengrui Medicine

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Teva Pharmaceutical Industries

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Lurasidone Hydrochloride Tablet Market

Figure 4: Global Lurasidone Hydrochloride Tablet Market: Drivers

Figure 5: Global Lurasidone Hydrochloride Tablet Market: Challenges

Figure 6: Global Lurasidone Hydrochloride Tablet Market: Trends

Figure 7: Global Lurasidone Hydrochloride Tablet Market: Opportunity

Figure 8: Global Lurasidone Hydrochloride Tablet Market: Restraint

Figure 9: Global Lurasidone Hydrochloride Tablet Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Lurasidone Hydrochloride Tablet Market Value (USD Million) By Region

Figure 15: Global Lurasidone Hydrochloride Tablet Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Lurasidone Hydrochloride Tablet Market Value (USD Million) By Region

Figure 23: Global Lurasidone Hydrochloride Tablet Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

71 items

Table 1: Market Segmentation Analysis

Table 2: Global Lurasidone Hydrochloride Tablet Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Lurasidone Hydrochloride Tablet Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Lurasidone Hydrochloride Tablet Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Lurasidone Hydrochloride Tablet Market Value (USD Million) By Region

Table 10: Global Lurasidone Hydrochloride Tablet Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Lurasidone Hydrochloride Tablet Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Lurasidone Hydrochloride Tablet Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Lurasidone Hydrochloride Tablet Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Sumitomo Pharma America, Inc. Basic Information And Sales Area

Table 31: Sumitomo Pharma America, Inc.. Products Portfolio

Table 32: Dr. Reddy's Laboratories Limited Basic Information And Sales Area

Table 33: Dr. Reddy's Laboratories Limited. Products Portfolio

Table 34: Teva Takeda Yakuhin Ltd. Basic Information And Sales Area

Table 35: Teva Takeda Yakuhin Ltd.. Products Portfolio

Table 36: LTL Pharma Co.,Ltd. Basic Information And Sales Area

Table 37: LTL Pharma Co.,Ltd.. Products Portfolio

Table 38: Mylan Pharmaceuticals Basic Information And Sales Area

Table 39: Mylan Pharmaceuticals. Products Portfolio

Table 40: Organon LLC Basic Information And Sales Area

Table 41: Organon LLC. Products Portfolio

Table 42: Santen Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 43: Santen Pharmaceutical Co.,Ltd.. Products Portfolio

Table 44: Hengrui Medicine Basic Information And Sales Area

Table 45: Hengrui Medicine. Products Portfolio

Table 46: Teva Pharmaceutical Industries Basic Information And Sales Area

Table 47: Teva Pharmaceutical Industries. Products Portfolio

Table 48: Global Market Value (USD Million) (2025-2032) By Application

Table 49: Global Market Share (%) By Application (2032)

Table 50: Global Market Value (USD Million) (2025-2032) By Types

Table 51: Global Market Share (%) By Types (2032)

Table 52: Global Lurasidone Hydrochloride Tablet Market Value (USD Million) By Region

Table 53: Global Lurasidone Hydrochloride Tablet Market Share (%) By Region (2025-2032)

Table 54: North America Market Value (USD Million) (2025-2032) By Country

Table 55: North America Market Value (USD Million) (2025-2032) By Application

Table 56: North America Market Value (USD Million) (2025-2032) By Types

Table 57: Europe Market Value (USD Million) (2025-2032) By Country

Table 58: Europe Market Value (USD Million) (2025-2032) By Application

Table 59: Europe Market Value (USD Million) (2025-2032) By Types

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 61: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 63: South America Market Value (USD Million) (2025-2032) By Country

Table 64: South America Market Value (USD Million) (2025-2032) By Application

Table 65: South America Market Value (USD Million) (2025-2032) By Types

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 67: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 69: Research Programs/Design For This Report

Table 70: Key Data Information From Secondary Sources

Table 71: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Lurasidone Hydrochloride Tablet Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	4.70 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sumitomo Pharma America, Inc.; Dr. Reddy's Laboratories Limited; Teva Takeda Yakuhin Ltd.; LTL Pharma Co.,Ltd.; Mylan Pharmaceuticals; Organon LLC; Santen Pharmaceutical Co.,Ltd.; Hengrui Medicine; Teva Pharmaceutical Industries
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options